Total Liabilities for Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported total liabilities is $85.94B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
LLY
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$85.94B
YoY change
+33.4%
5Y CAGR
+16.1%
Peak year (2025)
$85.94B
Latest annual
$85.94B
Total Liabilities history chart for Eli Lilly (LLY) from 1985 to 2025
Total Liabilities history table for Eli Lilly (LLY) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $85.94B | +33.4% | ||
| 2024 | $64.44B | +21.3% | ||
| 2023 | $53.14B | +37.3% | ||
| 2022 | $38.71B | -2.4% | ||
| 2021 | $39.65B | -2.8% | ||
| 2020 | $40.81B | +11.5% | ||
| 2019 | $36.59B | +10.9% | ||
| 2018 | $33.00B | -0.9% | ||
| 2017 | $33.31B | +34.7% | ||
| 2016 | $24.73B | +17.9% | ||
| 2015 | $20.98B | +0.3% | ||
| 2014 | $20.92B | +18.8% | ||
| 2013 | $17.61B | -10.3% | ||
| 2012 | $19.63B | -2.5% | ||
| 2011 | $20.12B | +8.3% | ||
| 2010 | $18.59B | +3.6% | ||
| 2009 | $17.94B | -20.2% | ||
| 2008 | $22.48B | +68.1% | ||
| 2007 | $13.37B | +21.8% | ||
| 2006 | $10.97B | -20.4% | ||
| 2005 | $13.79B | -1.1% | ||
| 2004 | $13.95B | +17.1% | ||
| 2003 | $11.91B | +10.6% | ||
| 2002 | $10.77B | +15.4% | ||
| 2001 | $9.33B | +7.9% | ||
| 2000 | $8.64B | +10.6% | ||
| 1999 | $7.81B | -4.3% | ||
| 1998 | $8.17B | +5.1% | ||
| 1997 | $7.77B | -5.3% | ||
| 1996 | $8.21B | -8.6% | ||
| 1995 | $8.98B | -1.9% | ||
| 1994 | $9.15B | +81.1% | ||
| 1993 | $5.05B | +33.7% | ||
| 1992 | $3.78B | +13.4% | ||
| 1991 | $3.33B | -9.3% | ||
| 1990 | $3.68B | +75.8% | ||
| 1989 | $2.09B | +2.6% | ||
| 1988 | $2.04B | -7.9% | ||
| 1987 | $2.21B | +19.2% | ||
| 1986 | $1.86B | +18.5% | ||
| 1985 | $1.57B | — |
Total Liabilities values are taken from Eli Lilly's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Eli Lilly (LLY) most recent annual total liabilities stands at $85.94B (2025) – surged 33.4% year-over-year.
Eli Lilly total liabilities has recorded the values shown across consecutive periods, with a +16.1% compound annual growth rate over 2020–2025 (5 years).
Across the available history, total liabilities reached its high of $85.94B in 2025 and its low of $1.57B in 1985.
Eli Lilly (LLY) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $100.94B.
Eli Lilly Total Liabilities by Year
Eli Lilly Total Liabilities 2025: $85.94B
Eli Lilly total liabilities in 2025 was $85.94B, surged 33.4% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly Total Liabilities 2024: $64.44B
Eli Lilly total liabilities in 2024 was $64.44B, grew 21.3% from 2023.
Eli Lilly Total Liabilities 2023: $53.14B
Eli Lilly total liabilities in 2023 was $53.14B, surged 37.3% from 2022.
Eli Lilly Total Liabilities 2022: $38.71B
Eli Lilly total liabilities in 2022 was $38.71B, edged down 2.4% below 2021.
Eli Lilly Total Liabilities 2021: $39.65B
Eli Lilly total liabilities in 2021 was $39.65B.
See more financial history for Eli Lilly (LLY).
Sector peers — Total Liabilities
Companies in the same sector as Eli Lilly, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $56.81B | Healthcare |
Frequently asked questions
What is Eli Lilly's total liabilities?
- Latest reported total liabilities for Eli Lilly (LLY) is $85.94B (period ending December 31, 2025).
How has Eli Lilly total liabilities changed year-over-year?
- Eli Lilly (LLY) total liabilities changed +33.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Eli Lilly total liabilities?
- Eli Lilly (LLY) total liabilities compound annual growth rate is +16.1% over the most recent 5 years available.
When did Eli Lilly total liabilities hit its highest annual value?
- Eli Lilly total liabilities reached its highest annual value of $85.94B in 2025.
What was Eli Lilly total liabilities in 2024?
- Eli Lilly (LLY) total liabilities in 2024 was $64.44B.
What was Eli Lilly total liabilities in 2025?
- Eli Lilly (LLY) total liabilities in 2025 was $85.94B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LLY Overview
Company profile, financial tools, and key metrics
LLY Revenue Counter
Earns $2,067 every second. See per minute, hour, and day.
LLY Earnings Counter
Earns $654.44 per second net profit. See per minute, hour, and day.
LLY Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
LLY What If Invested
What if you had invested $1,000? See historical returns from any date.
LLY How It Makes Money
Discover visual breakdown of $65.18B in revenue — where it comes from and where it goes.
LLY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LLY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LLY Daily Price Character
Steady · 48.0% historical win rate (green days). Streaks & record days.
LLY Buybacks
0.43% TTM buyback yield. Shareholder yield & SBC comparison.
LLY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LLY Dividend Profile
Yield: 0.73%. Safety: 8/8. See full history.
LLY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LLY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.